Metabolomics Point out the Effects of Carfilzomib on Aromatic Amino Acid Biosynthesis and Degradation
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241813966 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ioanna Barla und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Analytical Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, 15771 Athens, Greece. Hauptthemen laut MEDLINE: Metabolomics, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
(1) Carfilzomib (Cfz) is an antineoplastic agent indicated for the treatment of multiple myeloma. However, its beneficial action is attenuated by the occurrence of cardiotoxicity and nephrotoxicity as the most common adverse effects. Presently, there is well-established knowledge on the pathomechanisms related to these side effects; however, the research on the metabolic alterations provoked by the drug is limited. (2) An in vivo simulation of Cfz-induced toxicity was developed in (i) Cfz-treated and (ii) control mice. An RP-HRMS-based protocol and an advanced statistical treatment were used to investigate the impact of Cfz on the non-polar metabolome. (3) The differential analysis classified the Cfz-treated and control mice and resulted in a significant number of identified biomarkers with AUC > 0.9. The drug impaired the biosynthesis and degradation of aromatic amino acids (AAA) and led to alterations of uremic toxins in the renal and urine levels. Furthermore, the renal degradation of tryptophan was affected, inducing its degradation via the kynurenine pathway. (4) The renal levels of metabolites showed impaired excretion and degradation of AAAs. Cfz was, finally, correlated with the biosynthesis of renal dopamine, explaining the biochemical causes of water and ion retention and the increase in systolic pressure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Analytical Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, 15771 Athens, Greece.
- Laboratory of Pharmacology, Department of Pharmacy, National and Kapodistrian University of Athens, 15771 Athens, Greece.
- School of Medicine, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, 11527 Athens, Greece.
ORCID-Profile: Meletios-Athanasios Dimopoulos, Evangelos Terpos, Nikolaos Thomaidis, Evangelos Gikas
Zitieren
APA
Barla, I., Efentakis, P., Lamprou, S., Gavriatopoulou, M., Dimopoulos, M. A., Terpos, E., Andreadou, I., Thomaidis, N., & Gikas, E. (2023). Metabolomics Point out the Effects of Carfilzomib on Aromatic Amino Acid Biosynthesis and Degradation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241813966
Vancouver
Barla I, Efentakis P, Lamprou S, Gavriatopoulou M, Dimopoulos MA, Terpos E, et al. Metabolomics Point out the Effects of Carfilzomib on Aromatic Amino Acid Biosynthesis and Degradation. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241813966
BibTeX
@article{Barla2023,
author = {Barla, Ioanna and Efentakis, Panagiotis and Lamprou, Sofia and Gavriatopoulou, Maria and Dimopoulos, Meletios-Athanasios and Terpos, Evangelos and Andreadou, Ioanna and Thomaidis, Nikolaos and Gikas, Evangelos},
title = {Metabolomics Point out the Effects of Carfilzomib on Aromatic Amino Acid Biosynthesis and Degradation},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241813966}
}
EUVIMED